News & Publications

Featured News

SEATTLE – May 16, 2012 – A study led by researchers at Fred Hutchinson Cancer Research Center has found that a next-generation, high-speed DNA-decoding technology called high-throughput sequencing can detect the earliest signs of potential relapse in nearly twice the number of leukemia patients as compared to flow cytometry, the current gold standard for detecting minimal residual disease. The results of the study, led by Hutchinson Center computational biologist Harlan Robins, Ph.D., are reported in the May 16 issue of Science Translational Medicine.

Media Coverage

More»

Subscribe to
Our Publications

Quest
Our quarterly magazine
 Subscribe

E-news from Fred Hutch
Our bi-monthly e-newsletter
 Subscribe

Petri Dish
Our science blog
 Subscribe

Survive & Thrive
For cancer survivors
 Subscribe

LifeLinks
For transplant recipients
 Subscribe

Annual Report
Fiscal year highlights

Center News
Weekly research news

Science Spotlight
Monthly review of Center-authored papers

News Releases
 Subscribe to RSS

Follow Us

 

Fred Hutchinson Cancer Research Center is a world leader in research to prevent, detect and treat cancer and other life-threatening diseases.